Importantly, using the xenograft model, we demonstrated that both tumor size and weight of mice injected with KDM4C stable knockdown HCC cells were decreased compared with those of mice injected with control HepG2 cells (Fig. 2C–F). This evidence concerns the gene KDM4C and neoplasm.